TEOSYAL® PURESENSE ULTIMATE (3ml)

Product Overview: TEOSYAL® PURESENSE ULTIMATE (3ml)

TEOSYAL® PURESENSE ULTIMATE (3ml) is a sterile, non-pyrogenic, transparent, highly cross-linked hyaluronic acid (HA) gel of non-animal origin, incorporating 0.3% lidocaine hydrochloride for enhanced patient comfort during treatment. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this high-viscosity formulation is specifically engineered for substantial volume creation and facial sculpting. Presented in a larger 3ml volume syringe, it is suitable for procedures requiring significant product quantity for deep injection into the subdermal or pre-periosteal layers, providing considerable structural support and augmentation.

This product is indicated for restoring large volumes and remodeling facial contours, particularly in areas like the cheeks, chin, jawline, and temples.

Note: TEOSYAL® PURESENSE ULTIMATE (3ml) is intended for use only by licensed medical professionals with thorough knowledge of facial anatomy and expertise in deep-plane injection techniques for volumizing fillers.

Mechanism of Action and Properties

TEOSYAL® PURESENSE ULTIMATE provides significant volumizing effects primarily due to its high concentration and degree of cross-linking of hyaluronic acid. Its dense, cohesive gel structure offers strong tissue support and lift upon deep injection. This formulation prioritizes projection and stability for effective facial sculpting. The hyaluronic acid component also contributes to tissue hydration. The integrated 0.3% lidocaine hydrochloride provides local anesthesia, significantly reducing patient discomfort during the procedure.

The extensive cross-linking contributes to the product’s resistance to degradation, offering an extended duration of effect, potentially up to 18 months, though individual results vary. The 3ml syringe volume facilitates treatment of larger areas or cases requiring substantial volume restoration in a single session.

Indications and Usage

TEOSYAL® PURESENSE ULTIMATE (3ml) is indicated for addressing significant volume loss and enhancing facial architecture, including:

• Malar (cheekbone) augmentation
• Zygomatic arch definition
• Chin projection and reshaping
• Jawline contouring and definition
• Correction of severe facial lipoatrophy
• Temple volumization

Administration requires deep injection techniques (subdermal or supra-periosteal) by qualified practitioners using appropriate needles or cannulas and adhering strictly to aseptic procedures. The 3ml volume is advantageous for bilateral treatments or significant augmentation needs.

Expected Outcomes

Professional application aims to achieve:

• Significant augmentation of facial volume in targeted areas
• Enhanced facial projection and definition (e.g., cheeks, chin)
• Improved overall facial contours and structure
• Correction of deep volume deficits and concavities
• Long-lasting results for facial remodeling
• Improved patient comfort due to lidocaine inclusion

Potential Adverse Events

Due to the deep injection placement and potentially large volumes used, practitioners must carefully discuss potential side effects. Possible adverse events include:

• Common Reactions (Typically Transient): Post-injection swelling, bruising, erythema (redness), pain, tenderness, palpable firmness or lumpiness at the injection site. These usually resolve within one to two weeks.
• Less Common/Rare but Serious Reactions: Prolonged swelling or firmness, significant hematoma, infection, inflammation, hypersensitivity/allergic reaction (to HA or lidocaine), nodule or granuloma formation (potentially delayed onset), skin discoloration, abscess formation, contour irregularities, vascular complications (compression or intravascular injection, rare but serious, requiring immediate intervention), nerve impingement/effects (rare), tissue necrosis (rare).

Thorough understanding of deep facial anatomy, safe injection planes, and management of potential complications is essential. Patients must report any severe, persistent, or concerning reactions promptly.

Storage Conditions

Store between 2°C and 25°C. Avoid freezing and direct sunlight exposure. Ensure packaging integrity before use.

Disclaimer: This summary is for informational purposes only. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE ULTIMATE (3ml) before administration for complete details on product characteristics, indications, contraindications, warnings, precautions, injection procedures, and potential adverse events.